Comox

Lloyd Laboratories, Inc🇵🇭 Food and Drug Administration - Philippines

Approval Id: 3b5567f0d8cd49ec
Drug Approval Philippines Name: Comox
Product Name: Comox
Registration Number: DRP-942
Brand Name: Comox
Generic Name: Co-Amoxiclav
Dosage Form: Powder For Suspension
Dosage Strength: 50 mg/62.5 mg per 5 mL
Manufacturer: Lloyd Laboratories, Inc
Trader: Aldril Pharmaceuticals, Inc.
Issuance Date: 28 November 2022
Expiry Date: 18 December 2027
Pharmacologic Category: Antibacterial (Penicillin + Beta-Lactamse Inhibitor combination)
Classification: Prescription Drug (Rx)

Approved

Agency

Philippines FDA

Country

🇵🇭

Approval Date

Jul 14, 2025

Approval ID

3b5567f0d8cd49ec

Type

Standard